Company Information
- Type:
- Company
- Country:
- United States of America
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Publicly Listed
- Global Compact Status:
- Active
- Participant Since
- 19 July 2013 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 July 2025
Financial Information
Affiliated Subsidiaries
| Country | Company Name |
|---|---|
| Netherlands | Janssen Netherlands |
Communication On Progress
| Published On | Title | Level/Status |
|---|---|---|
| 23-Jul-2024 | 2024 Communication on Progress | Submitted |
| 07-Jun-2023 | 2023 Communication on Progress | Submitted |
| 09-Jun-2022 | 2021 Johnson & Johnson Communication on Progress | Advanced |
| 10-Jun-2021 | 2020 Johnson & Johnson Communication on Progress | Advanced |
| 12-Jun-2020 | 2019 Johnson & Johnson Communication on Progress | Advanced |
| 13-Jun-2019 | 2018 Johnson & Johnson Communication on Progress | Advanced |
| 14-Jun-2018 | 2017 Johnson & Johnson UNGC Communication on Progress | Advanced |
| 17-Jun-2017 | 2016 Johnson & Johnson UNGC Communication on Progress | Advanced |
| 17-Jun-2016 | Communication on Progress | Active |
| 19-Jun-2015 | Communication on Progress | Active |
| 20-Jun-2014 | Communication on Progress | Active |
Note: Responsibility for the content of participants' public communication related to the Ten Principles of the UN Global Compact and their implementation lies with participants themselves and not with the UN Global Compact.
Note on levels: Not applicable refers to the period when the Communication on Progress (CoP) did not require differentiation levels. With the new CoP , for the 2022 Early Adopter Programme, and for 2023, there will be no differentiation levels.